US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.69

-0.4365-1.24%

Post-market: 34.710.0207+0.06%19:30 EDT

Volume:25.49K

Turnover:885.29K

Market Cap:96.44M

PE:- -

High:35.13

Open:35.13

Low:34.63

Close:35.13

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:1.14

T/O Rate:0.92%

Dividend:0.26

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Shanghai Shen Lian Biomedical's UB-221 Meets Primary Goal in Phase II Urticaria Trial

Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal

From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Transthera-B Doses First Patient in Phase II Trial of Tinengotinib Combined with Novel Endocrine Therapy for Advanced Metastatic Castration-Resistant Prostate Cancer in China

Kaiyuan Securities: Generic Drug Division Sees Recovery in Earnings Growth, With Innovative Drug and CDMO Transition Players Nearing Their Monetization Phase

朱保国功成身退，39岁刘大平能否引领丽珠穿越转型深水区？

Hefei Lifeon's Clinical Trial Application for a New Pain Relief Drug Combination Has Been Officially Accepted by the Regulator

Gan & Lee Pharmaceuticals Receives Clinical Trial Approval for Investigational Drug GLR1075 Injection

China Targets First-in-Class Drug Share Above 25% Globally by 2030 Under New Five-Year Plan

Ten Ministries Unveil 15th Five-Year Plan for Pharmaceutical Industry, Targeting over 20% Annual Growth in Innovative Drug Sector

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Pharma and Agriculture Outperform as Market Stays Rangebound, Structural Plays Dominate

A-Share Market Under Pressure After Rate Hike, Yet Innovative Drug Sector Shows Resilience

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/IBBQ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.6893,"timestamp":1789761600000,"preClose":35.1258,"halted":0,"volume":25488,"hourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"delay":0,"changeRate":-0.012426763233862154,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Market Closed","change":-0.4365,"latestTime":"09-18 16:00:00 EDT","open":35.13,"high":35.13,"low":34.6296,"amount":885294.380736,"amplitude":0.014246,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":35.11978,"aum":96412871.83,"dividendRate":0.007406,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.71,"preClose":34.6893,"latestTime":"19:30 EDT","volume":16,"amount":555.1565,"timestamp":1789774205753,"change":0.0207,"changeRate":0.000597,"amplitude":0},"volumeRatio":1.1394951737825971,"impliedVol":0.0457,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1394951737825971,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.014246,"preClose":35.1258,"low":34.6296,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.6893,"eps":0,"divideRate":0.007406,"volume":25488,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140751875","title":"Shanghai Shen Lian Biomedical's UB-221 Meets Primary Goal in Phase II Urticaria Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1140751875","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140751875?lang=en_us&edition=fundamental","pubTime":"2026-09-20 15:54","pubTimestamp":1789890856,"startTime":"0","endTime":"0","summary":"Shanghai Shen Lian Biomedical Corporation (688098.SH) has announced that its controlled subsidiary, Yangzhou Shizhiyuan Biotechnology Co., Ltd., achieved the primary endpoint in a Phase II clinical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","PSYK","MDTX","IBBQ","IBBJ","688098","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161329651","title":"Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1161329651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161329651?lang=en_us&edition=fundamental","pubTime":"2026-09-20 15:30","pubTimestamp":1789889447,"startTime":"0","endTime":"0","summary":"Shandong Ruifeng Chemical Co.,Ltd. (300243.SZ) has unveiled further details of its acquisition plan, which has been in the works for over a month. The company recently announced its intention to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0229","XLFI","ACTV","BK0177","IEFN","PBPH","IBBQ","BK0086","CANC","PEVC","AAUM","BK0028","UYG","BK4588","DFMC","FFSM","RSPH","PSP","MNA","GTPE","300243","BK4585","TMED","PRVT","RFG","IYH","TBXU","MMID","VXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166262684","title":"From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?","url":"https://stock-news.laohu8.com/highlight/detail?id=1166262684","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166262684?lang=en_us&edition=fundamental","pubTime":"2026-09-20 13:40","pubTimestamp":1789882836,"startTime":"0","endTime":"0","summary":"For a long stretch, innovative drug companies left investors with an impression of \"burning cash for stories.\" Huge R&D spending, commercialization that seemed perpetually distant, and valuations...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","MEDX","06978","LNGR","159992","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973164","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973164?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:34","pubTimestamp":1789763640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.55% to $385.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.17% to 7,650.50 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.This was the stock's third consecutive day of gains.Amgen Inc. closed 13.73% below its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.09% to $269.99, Pfizer Inc.  rose 0.07% to $27.66, and AbbVie Inc.  fell 0.02% to $263.96.Trading volume  eclipsed its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","BIB","LU0889565916.HKD","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","BK4534","SG9999001440.SGD","04332","BK4566","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599","LU0868494617.USD","LU2089984988.USD","PBE","AMGN","BK4139","LU2112291526.USD","IE00BJT1NW94.SGD","BBH","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138364495","title":"Transthera-B Doses First Patient in Phase II Trial of Tinengotinib Combined with Novel Endocrine Therapy for Advanced Metastatic Castration-Resistant Prostate Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1138364495","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138364495?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:58","pubTimestamp":1789729102,"startTime":"0","endTime":"0","summary":"Transthera-B (02617) has announced that the first patient has been dosed in its Phase II clinical trial in China evaluating tinengotinib (Jentai®; Tinengotinib, TT-00420) combined with novel...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MDTX","BK1161","BMED","PSYK","IBBJ","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195650513","title":"Kaiyuan Securities: Generic Drug Division Sees Recovery in Earnings Growth, With Innovative Drug and CDMO Transition Players Nearing Their Monetization Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1195650513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195650513?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:36","pubTimestamp":1789724171,"startTime":"0","endTime":"0","summary":"Kaiyuan Securities has released a research note indicating that China's domestic pharmaceutical raw material (API) industry is gradually stabilizing and recovering. Several companies are actively...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","MEDX","06978","159992","161027","BK1574","BK4139","CDMO","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184123652","title":"朱保国功成身退，39岁刘大平能否引领丽珠穿越转型深水区？","url":"https://stock-news.laohu8.com/highlight/detail?id=1184123652","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184123652?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:20","pubTimestamp":1789723244,"startTime":"0","endTime":"0","summary":"当国内老牌制药企业集体站在仿制药红利消退、创新药竞速加剧的时代分水岭，一场备受瞩目的企业权力交接正式完成。近日，丽珠集团公告披露，被誉为医药资本传奇人物、“太太口服液”创始人的朱保国宣布退休，辞去包括董事长在内的所有职务，同时他也卸任了另一家上市公司健康元的董事长职位。辞任后，朱保国依然是公司的实际控制人。朱保国卸任后，年仅39岁的总裁刘大平被推举为丽珠集团新任董事长，正式接掌这家老牌药企的航向。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBQ","LNGR","BK1161","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125664386","title":"Hefei Lifeon's Clinical Trial Application for a New Pain Relief Drug Combination Has Been Officially Accepted by the Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1125664386","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125664386?lang=en_us&edition=fundamental","pubTime":"2026-09-18 15:57","pubTimestamp":1789718264,"startTime":"0","endTime":"0","summary":"Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) has announced that it has recently received the formal acceptance notification from the National Medical Products Administration for its clinical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","003020","BMED","IBBJ","PSYK","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161909174","title":"Gan & Lee Pharmaceuticals Receives Clinical Trial Approval for Investigational Drug GLR1075 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1161909174","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161909174?lang=en_us&edition=fundamental","pubTime":"2026-09-18 15:42","pubTimestamp":1789717337,"startTime":"0","endTime":"0","summary":"Gan & Lee Pharmaceuticals (603087.SH) announced that it has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration for its investigational...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","BMED","603087","PSYK","MDTX","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146725689","title":"China Targets First-in-Class Drug Share Above 25% Globally by 2030 Under New Five-Year Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1146725689","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146725689?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:31","pubTimestamp":1789695077,"startTime":"0","endTime":"0","summary":"Ten government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the \"15th Five-Year Plan for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","IBBQ","MEDX","BK1161","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132425859","title":"Ten Ministries Unveil 15th Five-Year Plan for Pharmaceutical Industry, Targeting over 20% Annual Growth in Innovative Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1132425859","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132425859?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:24","pubTimestamp":1789694661,"startTime":"0","endTime":"0","summary":"On September 18, ten government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the 15th Five-Year Plan...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IBBQ","06978","LNGR","159992","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BK4533","LU1778281490.HKD","LU1559883803.SGD","LU1815336091.USD","LU2362541513.USD","IBB","SG9999001176.USD","LU0432979614.USD","TBXU","BBH","LU0757428866.USD","BK4139","LU2468319806.SGD","LU0079474960.USD","LU2362540622.SGD","IE00B19Z9Z06.USD","PBE","LU1674673691.USD","VRTX","IE00B19Z9P08.USD","LU1430594728.SGD","LU0889565916.HKD","IDNA","BK4585","LU0058720904.USD","GNMX","IBBQ","LU1069344957.HKD","BIB","BK4567","IE0002270589.USD","IE00BJT1NW94.SGD","LU2236285917.USD","LU1035775433.USD","SGXZ57979304.SGD","IE00B894F039.SGD","LU0109394709.USD","SG9999001176.SGD","LU2324357040.USD","IE00BFTCPJ56.SGD","IE00BZ9MQY76.HKD","VERX","IE0002141913.USD","LU2237438978.USD","LU2089984988.USD","LU0289739699.SGD","LU2462157665.USD","BK4532","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2456880835.USD","BK4588","SGXZ57979304.SGD","PBE","BBH","IBB","LU0079474960.USD","LU0417517546.SGD","LU2417539215.USD","LU2462157665.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4585","LU0889565916.HKD","BK4532","LU0432979614.USD","LU1674673428.USD","TBXU","IE00B2B36J28.USD","LU1093756325.SGD","GNMX","VRTX","LU0256863811.USD","LU2362541513.USD","LU1430594728.SGD","LU2237438978.USD","LU2324357040.USD","BK4567","BIB","IE00BFTCPJ56.SGD","LU2362541273.HKD","IE00B19Z9Z06.USD","IDNA","LU1585245621.USD","LU2468319806.SGD","IBBQ","LU0058720904.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD","BK4139","IE00BZ9MQY76.HKD","SG9999013999.USD","SG9999001176.USD","LU0823416689.USD","LU1069344957.HKD","LU2236285917.USD","LU0061475181.USD","IE0002270589.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1066051498.USD","LU1585245621.USD","BK4550","LU0289739699.SGD","SG9999015952.SGD","BK4139","BIB","IBBQ","LU0823416689.USD","BK4585","IE00B7SZLL34.SGD","LU0109394709.USD","LU1674673428.USD","SG9999015978.USD","LU0859254822.USD","BK4588","BK4578","LU0058720904.USD","SG9999015945.SGD","LU2357627491.SGD","LU1037948541.HKD","LU0234570918.USD","LU0965509010.AUD","LU1674673691.USD","LU0114720955.EUR","MEDI","LU1061106388.HKD","LU1023059063.AUD","LU1934455277.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1571399168.USD","BK4568","IE0002270589.USD","BK4583","IE00B3T34201.USD","LU2468319806.SGD","LU0122379950.USD","LU2087621335.USD","LU1934455194.USD","LU0965509283.SGD","LU1839511570.USD","LU2324357040.USD","LU0889565916.HKD","LU2112291526.USD","GILD","BK4532","LU0965508806.USD","LU1934455863.HKD","LU1430594728.SGD","SG9999015986.USD","TBXU","LU0861579265.USD","IBB","IE00BSNM7G36.USD","LU0320765992.SGD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4566","TMED","LU0965509101.SGD","LU1778281490.HKD","LU2089984988.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BBH","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","IBB","LU1037948897.HKD","IBBQ","IE00BSNM7G36.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","WDNA","IE00B7SZLL34.SGD","BK4534","SG9999015986.USD","BBH","LU1585245621.USD","GILD","LU0122379950.USD","LU0965509010.AUD","LU0965509101.SGD","LU0114720955.EUR","LU0859254822.USD","LU2089984988.USD","LU1061106388.HKD","LU0234570918.USD","TMED","LU2357627491.SGD","MRNA","LU1778281490.HKD","LGHT","BK4501","LU0861579265.USD","LU0882574055.USD","LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","BK4568","LU0289739699.SGD","LU1934455863.HKD","MEDI","GNOM","BIB","BK4551","MRNY","MRNX","IE00B19Z3581.USD","LU1674673428.USD","TBXU","BMED","BK4578","LU1839511570.USD","BK4566","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991067","title":"FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991067","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991067?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:35","pubTimestamp":1789670130,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Fayuvi, which it calls “the first treatment for pediatric patients with mucopolysaccharidosis type I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","LABU","SYNB","LFSC","BK4588","TBXU","IBBQ","GNOM","CNCR","IBB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN","IE0009355771.USD","BK4566","TBXU","IE00B2B36J28.USD","LU0109394709.USD","BIB","LU1023059063.AUD","PJP","IE00BFTCPJ56.SGD","LU2242646821.SGD","BBH","LU1061106388.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4199","SG9999001440.SGD","PBE","IBBQ","IE00BJT1NW94.SGD","BK4599","LU0289739699.SGD","LU1983299246.USD","LU0320765992.SGD","BK4533","BK4585","ITP","IBB","LU0058720904.USD","LU2112291526.USD","BK4588","LU2468319806.SGD","BK4534","LU0889565916.HKD","LU1057294990.SGD","LU2089984988.USD","LU0868494617.USD","LU1571399168.USD","LU2242652126.USD","BK4139","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184295572","title":"Pharma and Agriculture Outperform as Market Stays Rangebound, Structural Plays Dominate","url":"https://stock-news.laohu8.com/highlight/detail?id=1184295572","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184295572?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:41","pubTimestamp":1789656105,"startTime":"0","endTime":"0","summary":"Chinese equities closed mixed on September 17, with major indices hovering in a consolidation pattern. Innovative drugs, agriculture, autos, and shipping bucked the trend with notable gains, while...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","159041","BK1161","IBBQ","BK1574","MEDX","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178906271","title":"A-Share Market Under Pressure After Rate Hike, Yet Innovative Drug Sector Shows Resilience","url":"https://stock-news.laohu8.com/highlight/detail?id=1178906271","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178906271?lang=en_us&edition=fundamental","pubTime":"2026-09-17 21:12","pubTimestamp":1789650727,"startTime":"0","endTime":"0","summary":"After the Federal Reserve's rate hike was confirmed, A-shares experienced a midday pullback with all three major indices closing lower. The market absorbed the major fundamental event with some...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLTW","MEDX","BK1574","83130","159992","US30Y.BOND","03188","06978","US5Y.BOND","07233","US2Y.BOND","BK1147","159982","IBBQ","US6M.BOND","82846","83188","03130","02846","US10Y.BOND","TLT","US7Y.BOND","399300","US12M.BOND","TMF","02827","LNGR","BK1161","US3Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","IE00B4R5TH58.HKD","PJP","BK4599","LU2242646821.SGD","LU1061106388.HKD","BK4530","BK4581","PBE","XLV","LU0320765992.SGD","XBI","LU0889565916.HKD","LU0128526141.USD","BK4139","BK4533","BK4534","BIB","IE0009355771.USD","IBBQ","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","TBXU","IE0002141913.USD","LU0289739699.SGD","LU0757428866.USD","CRL","IE00BJT1NW94.SGD","IE00BFMHRM44.USD","LU0029874061.USD","LU1983299246.USD","LU1815336091.USD","HCSG","LABU","LU0122379950.USD","IE00B2B36J28.USD","BK4121","SG9999001440.SGD","LU0390134368.USD","BK4566","BBH","LU0868494617.USD","BK4585","LU2468319806.SGD","BK4588","LU2089984988.USD","BK4137","AMGN","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}